Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

  1. Spanjaart, A.M.
  2. Ljungman, P.
  3. de La Camara, R.
  4. Tridello, G.
  5. Ortiz-Maldonado, V.
  6. Urbano-Ispizua, A.
  7. Barba, P.
  8. Kwon, M.
  9. Caballero, D.
  10. Sesques, P.
  11. Bachy, E.
  12. Di Blasi, R.
  13. Thieblemont, C.
  14. Calkoen, F.
  15. Mutsaers, P.
  16. Maertens, J.
  17. Giannoni, L.
  18. Nicholson, E.
  19. Collin, M.
  20. Vaz, C.P.
  21. Metafuni, E.
  22. Martinez-Lopez, J.
  23. Dignan, F.L.
  24. Ribera, J.-M.
  25. Nagler, A.
  26. Folber, F.
  27. Sanderson, R.
  28. Bloor, A.
  29. Ciceri, F.
  30. Knelange, N.
  31. Ayuk, F.
  32. Kroger, N.
  33. Kersten, M.J.
  34. Mielke, S.
  35. Montrer des auteurs +
Revue:
Leukemia

ISSN: 1476-5551,  0887-6924

Année de publication: 2021

Volumen: 35

Número: 12

Pages: 3585-3588

Type: Article

DOI: 10.1038/S41375-021-01466-0 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus